1. Females' participation in psychopharmacology research as authors, editors, and subjects
- Author
-
Karen Van Wagner, John J. Panos, Alan Poling, Kelly P. Bradley, Amy Durgin, Lindsay K. Porter, and Marc Weeden
- Subjects
Male ,Publishing ,Pharmacology ,Gerontology ,medicine.medical_specialty ,Psychopharmacology ,Research Subjects ,Alternative medicine ,Authorship ,Research Personnel ,Psychiatry and Mental health ,Workforce ,medicine ,Humans ,Female ,Pharmacology (medical) ,Sex Distribution ,Psychology ,A determinant ,Clinical psychology - Abstract
This study determined the involvement of women as first authors and other authors for every article published in Experimental and Clinical Psychopharmacology, Pharmacology Biochemistry and Behavior, and Psychopharmacology in 1991, 1996, 2001, and 2006. Their involvement as editors also was determined. Women's participation as authors, but not as editors, slightly increased over time. In 2006, 43% of first authors, 38% of other authors, and 24% of editors were women. The gender of subjects was examined for the same years and journals, but could not be determined for 6% and 9% of articles employing nonhuman and human subjects, respectively. In 2006, when subjects' gender could be determined, 77% of articles involving nonhuman subjects used only males, 9% only females, and 14% both males and females. In articles using human subjects in that same year, 17% involved only males, 6% only females, and 77% both males and females. Women researchers clearly make substantial contributions to the psychopharmacology literature, but are nonetheless underrepresented as editors. Findings regarding subjects indicate that there is growing recognition of the importance of gender as a determinant of drug effects, although the vast majority of nonhuman studies continue to involve only male subjects.
- Published
- 2009
- Full Text
- View/download PDF